Enhancement of dissolution and oral bioavailability of lacidipine via pluronic P123/F127 mixed polymeric micelles: formulation, optimization using central composite design and in vivo bioavailability study

References

• Abdelbary G, Makhlouf A. (2014). Adoption of polymeric micelles to enhance the oral bioavailability of dexibuprofen: formulation, in-vitro evaluation and in-vivo pharmacokinetic study in healthy human volunteers. Pharm Dev Technol 19:717–27.
   PubMed Web of Science ®Google Scholar
• Abdelbary GA, Tadros MI. (2013). Brain targeting of olanzapine via intranasal delivery of core-shell difunctional block copolymer mixed nanomicellar carriers: in vitro characterization, ex vivo estimation of nasal toxicity and in vivo biodistribution studies. Int J Pharm 452:300–10.
   PubMed Web of Science ®Google Scholar
• Alakhov V, Pietrzynski G, Patel K, et al. (2004). Pluronic block copolymers and Pluronic poly(acrylic acid) microgels in oral delivery of megestrol acetate. J Pharm Pharmacol 56:1233–41.
   PubMed Web of Science ®Google Scholar
• Aliabadi HM, Shahin M, Brocks DR, Lavasanifar A. (2008). Disposition of drugs in block copolymer micelle delivery systems: from discovery to recovery. Clin Pharmacokinet 47:619–34.
   PubMed Web of Science ®Google Scholar
• Allen C, Maysinger D, Eisenberg A. (1999). Nano-engineering block copolymer aggregates for drug delivery. Colloids Surf B 16:3–27.
   Web of Science ®Google Scholar
• Basalious EB, Shawky N, Badr-Eldin SM. (2010). SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization. Int J Pharm 391:203–11.
   PubMed Web of Science ®Google Scholar
• Chen Y, Sha X, Zhang W, et al. (2013). Pluronic mixed micelles overcoming methotrexate multidrug resistance: in vitro and in vivo evaluation. Int J Nanomed 8:1463–76.
   PubMed Web of Science ®Google Scholar
• Darekar T, Aithal KS, Shirodkar R, et al. (2016). Characterization and in vivo evaluation of lacidipine inclusion complexes with β-cyclodextrin and its derivatives. J Incl Phenom Macrocycl Chem 84:225–35.
   Web of Science ®Google Scholar
• Dinda SC, Pand SK. (2014). Formulation and in-vitro/in-vivo assessment of enhanced bioavailability of lacidipine using Nanopure technique. Albanian J Pharm Sci 1:20–5.
   Google Scholar
• El-Mahrouk GM, El-Gazayerly ON, Aboelwafa AA, Taha MS. (2014). Chitosan lactate wafer as a platform for the buccal delivery of tizanidine HCl: in vitro and in vivo performance. Int J Pharm 467:100–12.
   PubMed Web of Science ®Google Scholar
• El Mahrouk GM, Elgazayerly ON, Aboelwafa AA, Taha MS. (2014). Hot-melts in buccoadhesive patches: an approach for bioavailability enhancement of highly-metabolized drugs with short elimination half-life. Eur J Pharm Biopharm 88:1005–11.
   PubMed Web of Science ®Google Scholar
• Elkasabgy NA, Elsayed I, Elshafeey AH. (2014). Design of lipotomes as a novel dual functioning nanocarrier for bioavailability enhancement of lacidipine: in-vitro and in-vivo characterization. Int J Pharm 472:369–79.
   PubMed Web of Science ®Google Scholar
• Gannu R, Palem CR, Yamsani VV, et al. (2010). Enhanced bioavailability of lacidipine via microemulsion based transdermal gels: formulation optimization, ex vivo and in vivo characterization. Int J Pharm 388:231–41.
   PubMed Web of Science ®Google Scholar
• Gaucher G, Dufresne MH, Sant VP, et al. (2005). Block copolymer micelles: preparation, characterization and application in drug delivery. J Control Release 109:169–88.
   PubMed Web of Science ®Google Scholar
• Gaucher G, Satturwar P, Jones MC, et al. (2010). Polymeric micelles for oral drug delivery. Eur J Pharm Biopharm 76:147–58.
   PubMed Web of Science ®Google Scholar
• Gaumet M, Vargas A, Gurny R, Delie F. (2008). Nanoparticles for drug delivery: The need for precision in reporting particle size parameters. Eur J Pharm Biopharm 69:1–9.
   PubMed Web of Science ®Google Scholar
• Geng Y, Zhao L, Zhao J, et al. (2014). Development of a supercritical fluid chromatography-tandem mass spectrometry method for the determination of lacidipine in beagle dog plasma and its application to a bioavailability study. J Chromatogr B Analyt Technol Biomed Life Sci 945-946:121–6.
   PubMed Web of Science ®Google Scholar
• Gonnissen Y, Goncalves SI, De Geest BG, et al. (2008). Process design applied to optimise a directly compressible powder produced via a continuous manufacturing process. Eur J Pharm Biopharm 68:760–70.
   PubMed Web of Science ®Google Scholar
• Hanes DS, Weir MR. 2005. Calcium antagonists. In: E.J. Battegay, G.Y.H. Lip, G.L. Bakris eds. Hypertension: principles and practice. USA: Taylor & Francis Group, 517–530.
   Google Scholar
• Kabanov AV, Batrakova EV, Miller DW. (2003). P luronic block copolymers as modulators of drug efflux transporter activity in the blood–brain barrier. Adv Drug Deliv Rev 55:151–64.
   PubMed Web of Science ®Google Scholar
• Kassem MA, Elmeshad AN, Fares AR. (2016). Enhanced solubility and dissolution rate of lacidipine nanosuspension: formulation via antisolvent sonoprecipitation technique and optimization using box-behnken design. AAPS PharmSciTech 18:983–96.
   PubMed Web of Science ®Google Scholar
• Kataoka K, Harada A, Nagasaki Y. (2001). Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 47:113–31.
   PubMed Web of Science ®Google Scholar
• Kedar U, Phutane P, Shidhaye S, Kadam V. (2010). Advances in polymeric micelles for drug delivery and tumor targeting. Nanomedicine 6:714–29.
   PubMed Web of Science ®Google Scholar
• Kulthe SS, Inamdar NN, Choudhari YM, et al. (2011). Mixed micelle formation with hydrophobic and hydrophilic Pluronic block copolymers: implications for controlled and targeted drug delivery. Colloids Surf B Biointerfaces 88:691–6.
   PubMed Web of Science ®Google Scholar
• Lu Y, Park K. (2013). Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs. Int J Pharm 453:198–214.
   PubMed Web of Science ®Google Scholar
• Montgomery DC. 2001. Design and analysis of experiments, 5th ed. New York (USA): John Wiley & Sons Inc.
   Google Scholar
• Mu CF, Balakrishnan P, Cui FD, et al. (2010). The effects of mixed MPEG-PLA/Pluronic copolymer micelles on the bioavailability and multidrug resistance of docetaxel. Biomaterials 31:2371–9.
   PubMed Web of Science ®Google Scholar
• Mukharya A, Chaudhary S, Mansuri N, Misra AK. (2012). Solid-state characterization of lacidipine/PVP K(29/32) solid dispersion primed by solvent co-evaporation. Int J Pharma Investig 2:90–6.
   PubMedGoogle Scholar
• Parmar A, Parekh P, Bahadur P. (2013). Solubilization and release of a model drug nimesulide from PEO–PPO–PEO block copolymer core–shell micelles: effect of size of PEO blocks. J Solution Chem 42:80–101.
   Web of Science ®Google Scholar
• Rangel-Yagui CO, Pessoa A, Jr., Tavares LC. (2005). Micellar solubilization of drugs. J Pharm Pharm Sci 8:147–65.
   PubMed Web of Science ®Google Scholar
• Rupp C, Steckel H, Muller BW. (2010). Solubilization of poorly water-soluble drugs by mixed micelles based on hydrogenated phosphatidylcholine. Int J Pharm 395:272–80.
   PubMed Web of Science ®Google Scholar
• Sun M, Wu C, Fu Q, et al. (2016). Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions. Int J Pharm 503:238–46.
   PubMed Web of Science ®Google Scholar
• Wei Z, Hao J, Yuan S, et al. (2009). Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization. Int J Pharm 376:176–85.
   PubMed Web of Science ®Google Scholar
• Wu C, Kou L, Ma P, et al. (2015). Interspecies prediction of oral pharmacokinetics of different lacidipine formulations from dogs to human: physiologically based pharmacokinetic modelling combined with biorelevant dissolution. RSC Adv 5:19844–52.
   Web of Science ®Google Scholar
• Xia D, Quan P, Piao H, et al. (2010). Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability. Eur J Pharm Sci 40:325–34.
   PubMed Web of Science ®Google Scholar
• Yong CS, Lee MK, Park YJ, et al. (2005). Enhanced oral bioavailability of ibuprofen in rats by poloxamer gel using poloxamer 188 and menthol. Drug Dev Ind Pharm 31:615–22.
   PubMed Web of Science ®Google Scholar
• Yu JN, Zhu Y, Wang L, et al. (2010). Enhancement of oral bioavailability of the poorly water-soluble drug silybin by sodium cholate/phospholipid-mixed micelles. Acta Pharmacol Sin 31:759–64.
   PubMed Web of Science ®Google Scholar
• Zhang H, Hollis CP, Zhang Q, Li T. (2011). Preparation and antitumor study of camptothecin nanocrystals. Int J Pharm 415:293–300.
   PubMed Web of Science ®Google Scholar
• Zhang W, Shi Y, Chen Y, et al. (2011b). The potential of Pluronic polymeric micelles encapsulated with paclitaxel for the treatment of melanoma using subcutaneous and pulmonary metastatic mice models. Biomaterials 32:5934–44.
   PubMed Web of Science ®Google Scholar
• Zhao J, Luo L, Fu Q, et al. (2015). Improved oral bioavailability of lacidipine using nanosuspension technology: inferior in vitro dissolution and superior in vivo drug absorption Verus Lacipil (R). Curr Drug Deliv 13:764–73.
   Web of Science ®Google Scholar
• Zhao L, Du J, Duan Y, et al. (2012). Curcumin loaded mixed micelles composed of Pluronic P123 and F68: preparation, optimization and in vitro characterization. Colloids Surf B Biointerf 97:101–8.
   PubMed Web of Science ®Google Scholar